Hyalace features a pioneering 64mg hyaluronic acid complex combining high-molecular (H-HA) and low-molecular weight (L-HA) fractions. Clinically formulated to increase collagen synthesis by 38%* and improve skin elasticity scores by 27%* in FDA-monitored trials. This medical-grade dermal booster delivers immediate hydration while stimulating long-term structural rejuvenation through fibroblast activation.

*Based on BNC Global clinical data (2023), individual results may vary

PRIMARY CLINICAL BENEFITS

PATENTED DELIVERY TECHNOLOGY

PROFESSIONAL APPLICATION

1. Cleanse with chlorhexidine post-anesthesia
2. Administer at 0°-45° in shallow subdermal layer
3. Apply slight pressure post-injection
4. Avoid UV/sauna exposure (72hrs)
5. Clinical follow-up at 2 weeks

MEDICAL DISCLAIMER: For certified practitioner use only. Contraindicated for patients with bleeding disorders or immunosuppression. Storage: 1-25°C protected from light. Optimal results observed after 1-2 sessions. Clinical outcomes vary significantly based on individual biological response, technique compliance, and skin condition. Manufacturer not liable for off-protocol use.